Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial

著者: Joseph A. Murray, Dina Wassaf, Karen Dunn, Samir Arora, Peter Winkle, Helen Stacey, Simon Cooper, Kaela E. Goldstein, Rajesh V. Manchanda, Stephan Kontos, Kristie M. Grebe - The Lancet 2023 被引用: 58